Skip to main content

Advertisement

Log in

Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Malignant pleural effusion (MPE) results from primary mesothelioma or the spreading of metastatic cancer. Both talc pleurodesis (TP) and indwelling pleural catheter (IPC) improve MPE symptoms. We performed a meta-analysis of randomized controlled trials to compare the efficacy of TP with that of IPC in patients with MPE. PubMed, EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched for studies published before February 2020. Individual effect sizes were standardized, and a meta-analysis was conducted to calculate a pooled effect size by using random effects models. In total, 4 trials with 500 patients were reviewed. Difference in pleurodesis success rate and change in dyspnea scores at 4 and 6 weeks between MPE patients treated with IPC and those treated with TP for pleurodesis were nonsignificant. The number of hospital inpatient days was significantly lower among patients who were treated with IPC (weight mean difference: 2.19; 95% confidence interval 0.70–3.67) than among those who were treated with TP. No significant difference was shown in adverse event profile between patients treated with IPC and those treated with TP for pleurodesis. In conclusion, both TP and IPC are equally effective in treating patients with MPE. The number of hospitalization days was significantly lower for patients who were treated with IPC, but the magnitude of the difference is of uncertain clinical importance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

EQ-5D-5 L:

EuroQoL Group 5-Dimensions 5-Level Questionnaire

IPC:

Indwelling pleural catheter

MBS:

Modified Borg Scale

MeSH:

Medical subject headings

MPE:

Malignant pleural effusion

QLQ-C30:

quality of life questionnaire-core 30

QoL:

Quality of life

RCT:

Randomized controlled trials

RoB:

Risk of bias

RR:

Risk ratios

TP:

Talc pleurodesis

WMD:

Weighted mean difference

References

  1. Clive AO, Jones HE, Bhatnagar R, Preston NJ, Maskell N (2016) Interventions for the management of malignant pleural effusion: a network meta-analysis. Cochrane Database Syst Rev 5:CD010529. https://doi.org/10.1002/14651858.CD010529.pub2

    Article  Google Scholar 

  2. Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, Harrison RN, Mustafa RA, Bishop LJ, Ahmed L, West A, Holme J, Evison M, Munavvar M, Sivasothy P, Herre J, Cooper D, Roberts M, Guhan A, Hooper C, Walters J, Saba TS, Chakrabarti B, Gunatilake S, Psallidas I, Walker SP, Bibby AC, Smith S, Stadon LJ, Zahan-Evans NJ, Lee YCG, Harvey JE, Rahman NM, Miller RF, Maskell NA (2018) Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med 378:1313–1322. https://doi.org/10.1056/NEJMoa1716883

    Article  CAS  PubMed  Google Scholar 

  3. Porcel JM, Sole C, Salud A, Bielsa S (2017) Prognosis of cancer with synchronous or metachronous malignant pleural effusion. Lung 195:775–779. https://doi.org/10.1007/s00408-017-0050-1

    Article  PubMed  Google Scholar 

  4. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, BTS Pleural Disease Guideline Group (2010) Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 65 (Suppl 2):ii32–i40. https://doi.org/10.1136/thx.2010.136994

  5. Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH (2014) Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS ONE 9:e87060. https://doi.org/10.1371/journal.pone.0087060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Porcel JM, Lui MM, Lerner AD, Davies HE, Feller-Kopman D, Lee YC (2017) Comparing approaches to the management of malignant pleural effusions. Expert Rev Respir Med 11:273–284. https://doi.org/10.1080/17476348.2017.1300532

    Article  CAS  PubMed  Google Scholar 

  7. Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, Davies CW, Grayez J, Harrison R, Prasad A, Crosthwaite N, Lee YC, Davies RJ, Miller RF, Rahman NM (2012) Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion. JAMA 307:2383–2389. https://doi.org/10.1001/jama.2012.5535

    Article  CAS  PubMed  Google Scholar 

  8. Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, Horwood FC, Piccolo F, Lam DCL, Garske LA, Shrestha R, Kosky C, Read CA, Murray K, Lee YCG (2017) Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE Randomized Clinical Trial. JAMA 318:1903–1912. https://doi.org/10.1001/jama.2017.17426

    Article  PubMed  PubMed Central  Google Scholar 

  9. Boshuizen RC, Vd Noort V, Burgers JA, Herder GJM, Hashemi SMS, Hiltermann TJN, Kunst PW, Stigt JA, van den Heuvel MM (2017) A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer 108:9–14. https://doi.org/10.1016/j.lungcan.2017.01.019

    Article  CAS  PubMed  Google Scholar 

  10. Sørensen PG, Svendsen TL, Enk B (1984) Treatment of malignant pleural effusion with drainage with and without instillation of talc. Eur J Respir Dis 65:131–135

    PubMed  Google Scholar 

  11. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. http://www.cochrane-handbook.org

  12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34. https://doi.org/10.1016/j.jclinepi.2009.06.006

    Article  PubMed  Google Scholar 

  13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2

    Article  CAS  PubMed  Google Scholar 

  14. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727–1736. https://doi.org/10.1007/s11136-011-9903-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365

    Article  CAS  PubMed  Google Scholar 

  16. Gawron G, Gabrys J, Barczyk A (2013) Talc slurry pleurodesis via chest tube in department of pulmonology: a 24-case study. Pneumonol Alergol Pol 81:439–447

    PubMed  Google Scholar 

  17. Hunt BM, Farivar AS, Vallières E, Louie BE, Aye RW, Flores EE, Gorden JA (2012) Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg 94:1053–1057. https://doi.org/10.1016/j.athoracsur.2012.01.103

    Article  PubMed  Google Scholar 

  18. Fysh ETH, Waterer GW, Kendall PA, Bremner PR, Dina S, Geelhoed E, McCarney K, Morey S, Millward M, Musk AWB, Lee YCG (2012) Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest 142:394–400. https://doi.org/10.1378/chest.11-2657

    Article  PubMed  Google Scholar 

  19. Asciak R, Hallifax RJ, Mercer RM, Hassan M, Wigston C, Wrightson JM, Psallidas I, Rahman NM (2018) The hospital and patient burden of indwelling pleural catheters: a retrospective case series of 210 indwelling pleural catheter insertions. Respiration 97:70–77. https://doi.org/10.1159/000491934

    Article  PubMed  Google Scholar 

  20. Srour N, Amjadi K, Forster AJ, Aaron S (2013) Management of malignant pleural effusion with indwelling pleural catheters or talc pleurodesis. Can Respir J 20:106–110. https://doi.org/10.1155/2013/842768

    Article  PubMed  PubMed Central  Google Scholar 

  21. Liou DZ, Serna-Gallegos D, Chan JL, Borgella J, Akhmerov S, Soukiasian HJ (2016) Survival difference in patients with malignant pleural effusions treated with pleural catheter or talc pleurodesis. Am Surg 82:995–999

    Article  PubMed  Google Scholar 

  22. Van Meter ME, McKee KY, Kohlwes RJ (2011) Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 26:70–76. https://doi.org/10.1007/s11606-010-1472-0

    Article  PubMed  Google Scholar 

  23. Muruganandan S, Azzopardi M, Fitzgerald DB, Shrestha R, Kwan BCH, Lam DCL, De Chaneet CC, Rashid Ali MRS, Yap E, Tobin CL, Garske LA, Nguyen PT, Stanley C, Popowicz ND, Kosky C, Thomas R, Read CA, Budgeon CA, Feller-Kopman D, Maskell NA, Murray K, Lee YCG (2018) Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med 6:671–680. https://doi.org/10.1016/S2213-2600(18)30288-1

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mr. Eugene, Chun-Chit Cheng for assistance with data collection, and Wallace Academic Editing for edition of the manuscript.

Funding

This research received no specific Grant from any funding agency in the public, commercial, or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ka-Wai Tam.

Ethics declarations

Disclosure

The authors Maggie Yeung, El-Wui Loh, Tung-Yu Tiong, and Ka-Wai Tam have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yeung, M., Loh, EW., Tiong, TY. et al. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Clin Exp Metastasis 37, 541–549 (2020). https://doi.org/10.1007/s10585-020-10042-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-020-10042-2

Keywords

Navigation